Fjarde Ap Fonden Quest Diagnostics Inc Transaction History
Fjarde Ap Fonden
- $9.89 Billion
- Q4 2024
A detailed history of Fjarde Ap Fonden transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 25,020 shares of DGX stock, worth $3.43 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
25,020
Previous 24,220
3.3%
Holding current value
$3.43 Million
Previous $3.76 Million
0.4%
% of portfolio
0.04%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding DGX
# of Institutions
946Shares Held
95.6MCall Options Held
379KPut Options Held
354K-
Vanguard Group Inc Valley Forge, PA14MShares$1.92 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.26MShares$722 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$528 Million0.07% of portfolio
-
Victory Capital Management Inc3.36MShares$461 Million0.48% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...